Ascendis Pharma

Perfil da empresa

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Descrição disponível em inglês.

Dados da empresa

Setor

Saúde

Indústria

Biotechnology

País

Estados Unidos

Sede

Tuborg Boulevard 12, 2900, Hellerup

Funcionários

1.189

Listagem

ASND · NASDAQ

Moeda

USD

Site

ascendispharma.com